Recombinant Macaca fuscata fuscata Gastricsin (PGC)

Basic Research Questions

• What is Gastricsin (PGC) and how does it differ from other gastric proteases?

Gastricsin, also known as pepsinogen C, is an aspartic proteinase belonging to the peptidase family A1. It functions as a digestive enzyme produced in the stomach and constitutes a major component of the gastric mucosa . Unlike pepsin A (derived from pepsinogen A), gastricsin has distinct substrate specificity and pH optima. In humans, gastricsin represents approximately 10-20% of total pepsinogens in gastric juice, with its relative proportion increasing after gastric stimulation . While the Japanese macaque (Macaca fuscata fuscata) gastricsin likely shares significant homology with human gastricsin, species-specific variations in amino acid sequence may confer unique enzymatic properties.

• How is gastricsin activated in physiological conditions?

Gastricsin is synthesized as an inactive zymogen (pepsinogen C) that includes a highly basic prosegment. The enzyme converts to its active form at low pH through sequential cleavage of this prosegment, a process carried out by the enzyme itself . This auto-activation mechanism is critical for its function in the acidic environment of the stomach. The activation process is similar to that of other pepsinogens but may have species-specific kinetics. The low pH environment triggers conformational changes that expose the active site, allowing the enzyme to begin proteolytic activity.

• What experimental models use Macaca fuscata fuscata gastricsin?

While the search results don't specifically address experimental models using Japanese macaque gastricsin, non-human primate models are valuable for comparative gastroenterology studies. Research using rhesus monkeys (Macaca mulatta) has examined gastric secretion patterns in response to feeding and insulin stimulation . These models provide insights into evolutionary conservation of digestive processes. Recombinant Macaca fuscata fuscata gastricsin would be particularly useful for cross-species comparison studies with human gastricsin to identify conserved functional domains and species-specific adaptations.

Advanced Research Questions

• What are the optimal conditions for storing and handling recombinant Macaca fuscata fuscata Gastricsin?

Based on recommendations for similar recombinant proteins, optimal storage conditions include:

For reconstitution, it is recommended to briefly centrifuge the vial prior to opening to bring contents to the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL with 5-50% glycerol as a stabilizing agent for long-term storage . Working aliquots should be prepared to minimize freeze-thaw cycles, as repeated freezing and thawing significantly reduces enzymatic activity .

• How can researchers verify the purity and activity of recombinant Macaca fuscata fuscata Gastricsin?

Multiple complementary approaches should be used:

a) Purity Assessment:

• SDS-PAGE analysis should demonstrate >85% purity, consistent with high-quality recombinant proteins

• High-performance ion-exchange chromatography can separate gastricsin from related proteases

• Mass spectrometry can confirm protein identity and detect potential contaminants

b) Activity Assessment:

• Enzymatic activity should be measured using specific substrates under pH-controlled conditions

• Comparison with standardized proteases (such as porcine pepsin A) can provide relative activity measurements

• Recovery studies should be performed to validate assay reliability, with expected recoveries of approximately 100% in properly optimized assays

c) Quality Control Parameters:

• Intra-assay CV (coefficient of variation) should be <9.0%

• Inter-assay CV should be <18.1%

• Linearity of measurement across the expected working range should be established

• How does gastricsin activity respond to physiological stimulation, and how can this be studied in experimental settings?

Gastricsin secretion patterns show distinct responses to physiological stimuli. Research has demonstrated that after both insulin and pentagastrin stimulation, the percentage of gastricsin relative to pepsins approximately doubles (from 10% to 20%) in human gastric juice . This increase suggests differential regulation of gastricsin compared to other pepsins.

For experimental studies:

a) Stimulation Protocols:

• Pentagastrin stimulation: Demonstrated to increase combined pepsin and gastricsin concentration approximately fourfold

• Insulin stimulation: Also produces significant increases in gastricsin secretion

• Feeding response: Can be used as a physiological stimulus to examine natural secretion patterns

b) Analytical Methods:

• High-performance ion-exchange chromatography provides superior separation of individual pepsins and gastricsin

• Quantification can be performed by relating chromatographic areas to standard amounts of a reference protease (e.g., porcine pepsin)

• ELISA-based detection systems can provide high sensitivity (down to 0.25ng/mL) for quantifying gastricsin in various biological samples

c) Control Considerations:

• Antrectomy (removal of the gastric antrum) abolishes acid secretory responses to histamine and insulin in non-human primates, indicating the importance of controlling for anatomical factors in secretion studies

• pH monitoring is essential as it directly affects enzyme activation and activity

• What are the key differences between human and Macaca fuscata fuscata gastricsin, and how do these impact comparative research?

While the precise sequence differences are not detailed in the search results, species variations in gastricsin likely affect:

a) Structural Properties:

• Amino acid substitutions may alter substrate binding pockets

• Post-translational modifications could differ between species

• Secondary and tertiary structural elements may show species-specific variations

b) Functional Properties:

• Substrate specificity might vary between human and macaque gastricsin

• pH optima and activation kinetics may differ

• Stability under various experimental conditions could show species-specific patterns

c) Analytical Considerations:

• Antibody cross-reactivity between human and macaque gastricsin should be verified

• Comparison studies should employ standardized conditions to isolate species-specific differences

• Reference standards specific to Macaca fuscata fuscata gastricsin should be established

• How can recombinant Macaca fuscata fuscata Gastricsin be used in gastric disease research?

Recombinant Macaca fuscata fuscata Gastricsin offers several applications in disease research:

a) Biomarker Studies:

• Human gastricsin serves as a biomarker for various gastric diseases, including Helicobacter pylori-related gastritis

• Comparative analysis between human and macaque gastricsin could identify conserved disease-associated modifications

• Standard curves using recombinant protein can calibrate quantitative assays for clinical samples

b) Functional Studies:

• Investigation of gastricsin's role in mucus degradation, which has implications in peptic ulceration

• Analysis of interactions with potential inhibitors for therapeutic development

• Study of gastricsin's role in protein digestion under normal versus pathological conditions

c) Genetic Studies:

• Polymorphisms in the human PGC gene are associated with susceptibility to gastric cancers

• Comparative genomics between human and macaque PGC genes could identify conserved functional domains and regulatory elements

• Structure-function relationships can be examined through site-directed mutagenesis studies

• What methodological approaches are recommended for comparative enzymatic studies between human and Macaca fuscata fuscata gastricsin?

For valid cross-species comparisons:

a) Standardized Activity Assays:

• Employ identical buffer systems, substrate concentrations, and assay conditions

• Determine enzyme kinetics (Km, Vmax) under multiple pH conditions

• Analyze temperature stability profiles for both enzymes

b) Inhibition Studies:

• Test sensitivity to pepstatin and other aspartic protease inhibitors

• Perform dose-response curves to determine IC50 values

• Analyze binding kinetics using surface plasmon resonance or similar techniques

c) Substrate Specificity Analysis:

• Compare hydrolytic activity using a panel of synthetic peptides with systematic sequence variations

• Analyze cleavage patterns of complex protein substrates

• Conduct competition assays to identify preferred substrates

d) Data Analysis Framework:

• Statistical comparison of enzymatic parameters using appropriate tests

• Computational modeling to predict structural basis for functional differences

• Phylogenetic analysis to place findings in evolutionary context

Research Applications and Techniques

• How can recombinant Macaca fuscata fuscata Gastricsin be used in developing standardized assays?

Recombinant gastricsin can serve as a valuable standard for assay development:

a) ELISA Development:

• Recombinant protein provides precisely quantifiable standard curves

• Current human gastricsin ELISAs offer detection ranges of 0.78-50ng/mL with sensitivities around 0.25ng/mL

• Calibration standards should include multiple concentrations spanning the expected range

b) Chromatographic Methods:

• High-performance ion-exchange chromatography can separate gastricsin from other gastric proteases

• Comparison against recombinant standards allows accurate quantification

• Analytical precision can be expected at 1.5-9.0% within-batch and 7.5-18.1% between-batch variation

c) Activity-Based Assays:

• Recombinant protein with known specific activity serves as a reference standard

• Zymography techniques can be optimized using recombinant gastricsin

• Recovery studies should achieve approximately 100% recovery across the assay range

• What are the challenges in expressing and purifying recombinant Macaca fuscata fuscata Gastricsin, and how can they be addressed?

Expression and purification of functional recombinant gastricsin presents several challenges:

a) Expression Systems:

• Mammalian cell expression systems are preferred for proper folding and post-translational modifications

• Expression region should encompass the mature protein (similar to residues 63-388 in homologous proteins)

• Tag selection impacts purification strategies and may affect protein activity

b) Purification Strategies:

• Multi-step purification typically required to achieve >85% purity

• Chromatographic methods must be optimized to separate active from inactive forms

• Process validation should include activity recovery measurements at each purification step

c) Activity Preservation:

• Buffer composition significantly impacts stability of purified enzyme

• Addition of stabilizing agents (e.g., glycerol) is recommended for storage

• Careful pH control during purification prevents premature activation

d) Quality Control:

• SDS-PAGE analysis should confirm expected molecular weight

• Western blot using specific antibodies verifies identity

• Activity assays confirm functional integrity of the final product